Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risedronate/Cholecalciferol Combination in Osteoporosis
NCT01675297Phase 4Completed
- Sponsor
- Hanlim Pharm
- Start
- Jul 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risedronate + cholecalciferol in osteoporosis, sponsored by Hanlim Pharm. Started Jul 2011; status: completed.
02
Drugs
risedronate + cholecalciferol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01675297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01675297.